Rockville , Jan. 18, 2024 (GLOBE NEWSWIRE) -- The global bone marrow transplantation market is pegged at a valuation of US$ 11.17 billion in 2024 and is forecasted to reach US$ 16 billion by the end of 2034. Increasing prevalence of blood cancer and growing healthcare expenditure are key factors projected to push global demand for bone marrow transplantation in the long run.
Get Free Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9336
Rapidly expanding aging population in countries such as Japan, Italy, and China is forecasted to create attractive new opportunities for bone marrow transplantation companies over the next 10 years and beyond. High investments in stem cell transplant R&D and growing awareness regarding bone marrow transplant treatments are also predicted to lead to market growth.
Bone marrow transplantation companies need to reduce the costs of the procedure if they wish to unlock the full growth potential of this marketplace on a global level. This study by Fact.MR, a market research and competitive intelligence provider, suggests that the preference for allogeneic bone marrow transplantation procedures is projected to stay high throughout the forecast period.
| Report Attribute | Details |
| Value Projection (2034) | US$ 16 Billion |
| Growth Rate (2024-2034) | 3.7% CAGR |
| No. of pages | 170 Pages |
| No. of Tables | 84 Tables |
| No. of Figures | 112 Figures |
Key Takeaways from Market Study
- The global bone marrow transplantation market is set to hold a revenue value of US$ 11.17 billion in 2024.
- Worldwide demand for bone marrow transplantation is predicted to rise at a CAGR of 3.7% from 2024 to 2034.
- The market is forecasted to attain a valuation of US$ 16 billion by 2034-end.
- High incidence of blood cancer, growing healthcare expenditure, increasing availability of novel bone marrow transplantation procedures, and high investments in healthcare research are key market drivers.
- Shortage of bone marrow donors and high costs of transplantation procedures are predicted to restrict market growth in the future.
- Demand for bone marrow transplantation in North America is forecasted to reach a value of US$ 5.54 billion by the end of the study period.
- Allogeneic bone marrow transplantation demand is forecasted to increase at a 3.8% CAGR over the next 10 years.
- Japan is predicted to account for 54.1% share of the East Asia market in 2024.
- Over the next decade, a majority of bone marrow transplantation procedures are projected to be conducted on patients diagnosed with leukemia.
“Stem cell research is projected to be crucial in revolutionizing the future of bone marrow transplantation, and this is why market players should focus on investing in this space,” says a Fact.MR analyst
Key Companies Profiled in This Report
- Merck Millipore Corporation
- ATCC Inc.
- Sanofi-Aventis LLC
- Cellular Dynamics International
- STEMCELL Technologies
- PromoCell GmbH
- American Type Culture Collection (ATCC) Inc.
- ReeLabs Pvt. Ltd.
- Mesoblast Ltd.
- HemaCare
Winning Strategy
Bone marrow transplantation companies should focus on increasing awareness regarding the benefits of this procedure and take advantage of government initiatives around the world that intend to do the same. Bone marrow transplantation providers should also make their procedures more cost-effective and affordable to promote their adoption in developing and under-developed countries.
Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=9336
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global bone marrow transplantation market, presenting historical demand data (2018 to 2023) and forecast statistics for the period (2024 to 2034).
The study divulges essential insights on the market based on transplant type (autologous bone marrow transplantation, allogeneic bone marrow transplantation), indication (leukemia, lymphoma, myeloma, myelodysplasia, myeloproliferative neoplasms, aplastic anemia, solid tumors, sickle cell anemia, thalassemia, others), and end user (hospitals, multispecialty clinics, ambulatory surgical centers), across six major regions of the world (North America, Europe, Latin America, East Asia, South Asia & Oceania, and the Middle East & Africa).
Explore More Related Studies Published by Fact.MR Research:
Bone Grafts and Substitutes Market: The global bone grafts and substitutes market reached a valuation of US$ 3.06 Billion in 2020. Sales of bone grafts and substitutes are slated to rise at a CAGR of 4.9% to reach US$ 4.44 Billion by the end of 2028.
Blood Cancer Diagnostics Market: The Blood Cancer Diagnostics landscape is slated to reach a valuation of US$ 28.57 Billion By 2032.
Bone Biopsy Systems Market: The global bone biopsy systems market is set to enjoy a valuation of US$ 227.6 million in 2022 and expand at a CAGR of 6% to reach US$ 408.9 million by the end of 2032.
About Fact.MR:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning. With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay ahead in the competitive landscape.
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Sales Team: sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog
